Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0859320100280030147
Journal of the Korean Society for Therapeutic Radiology and Oncology
2010 Volume.28 No. 3 p.147 ~ p.154
Combination Effect of Nimotuzumab with Radiation in Colorectal Cancer Cells
Shin Hye-Kyung

Kim Mi-Sook
Jeong Jae-Hoon
Abstract
Purpose:To investigate the radiosensitizing effect of the selective epidermal growth factor receptor (EGFR) inhibitor nimotuzumab in human colorectal cancer cell lines.

Methods: Four human colorectal cancer cell lines, HCT-8, LoVo, WiDr, and HCT-116 were treated with nimotuzumab and/or radiation. The effects on cell proliferation, viability, and cell cycle progression were measured by MTT, clonogenic survival assay, flow cytometry, and Western blot.

Results:An immunoblot analysis revealed that EGFR phosphorylation was inhibited by nimotuzumab in colorectal
cancer cell lines. Under these experimental conditions, pre-treatment with nimotuzumab increased radiosensitivity of colorectal cancer cell lines, except for cell line HCT-116. However, cell proliferation or cell cycle progression was not affected by the addition of nimotuzumab, irrespective of irradiation.

Conclusions: Nimotuzumab enhanced the radiosensitivity of colorectal cancer cells in vitro by inhibiting EGFR-mediated cell survival signaling. This study provided a rationale for the clinical application of the selective EGFR inhibitor, nimotuzumab in combination with radiation in colorectal cancer cells.
KEYWORD
Colorectal cancer, EGFR, Nimotuzumab, Radiation, Combined therapy
FullTexts / Linksout information
  
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø